BJS-British Journal of Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-08-13 145db63cm51暂无昵称

投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？

208 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-08-07 罗治文

偏重的研究方向：术后辅助
经验分享：2022年6月21日投稿，至今under review，没变过。
写于2022年8月7日
祈福帖

184 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-02-27 YJJJJJ 来自上海

21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？

174 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-10-21 ms6000001939754809 来自甘肃省

请问，该杂志如何知道有没有送外审啊？
2024-10-10 submited
当天就显示Under Review
截止10-21依然显示一位EO和Under Review
各位大佬，这种情况是还在内审吗？

55 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-03-17 xfzhang125

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肝胆胰外科
经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订

1 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2025-03-22 树树来自浙江省

偏重的研究方向：临床研究
经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新

23 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-01-20 ms7000000968733118 来自广东省

case report接收吗，同仁们

174 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-03-26 lancet1111 来自广东省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：.

108 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-10-18 YJJJJJ

怎么知道有没有送外审呢？送外审会有两个EO吗？

205 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007583, encodeId=1fa2100e58387, content=投稿第二天就under review 现在都70天了，状态还没更新，想请问下这种情况是什么原因啊？看了之前评论该杂志一审没这么长时间的，会不会是请了多个审稿人或者其他原因？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:19:05 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237128, encodeId=16c1123e12842, content=偏重的研究方向：术后辅助 经验分享：2022年6月21日投稿，至今under review，没变过。 写于2022年8月7日 祈福帖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93505319367, createdName=罗治文, createdTime=Sun Aug 07 18:25:57 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116623, encodeId=cc07211662376, content=21年的10月15投过一篇，11月1号外审拒稿。今年2月18投了个新稿，至27号还未拒稿，应该送审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Feb 27 00:40:02 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232053, encodeId=c86d22320535e, content=请问，该杂志如何知道有没有送外审啊？ 2024-10-10 submited 当天就显示Under Review 截止10-21依然显示一位EO和Under Review 各位大佬，这种情况是还在内审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6ee6493282, createdName=ms6000001939754809, createdTime=Mon Oct 21 08:51:59 CST 2024, time=2024-10-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1203405, encodeId=6881120340506, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肝胆胰外科 经验分享：刚刚一篇BJS接收，多中心回顾性研究。BJS突出外科实用性和创新性，以及数据可靠性。因此非常难，国内发表BJS很少。我们国家偏重基础研究，但是临床研究，特别是研究者发起的临床研究差距真的很大。希望临床医生能更注重临床研究，引领国内和国际指南的修订, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Thu Mar 17 11:17:23 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257296, encodeId=4381225e2963c, content=偏重的研究方向：临床研究 经验分享：3-16号投稿然后就under review了，今天是3月22日，还没有消息，后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5531657830, createdName=树树, createdTime=Sat Mar 22 18:40:43 CST 2025, time=2025-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110955, encodeId=3dd12110955e2, content=case report接收吗，同仁们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999e8158108, createdName=ms7000000968733118, createdTime=Fri Jan 20 09:32:35 CST 2023, time=2023-01-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195378, encodeId=17eb21953e8e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Mar 26 09:41:15 CST 2024, time=2024-03-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1061613, encodeId=7a691061613b3, content=怎么知道有没有送外审呢？送外审会有两个EO吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Oct 18 21:24:38 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 衣谷

如何让审稿人读完摘要就可以了解我的研究？

119 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务